Lv62
1958 积分 2022-08-15 加入
Tarlatamab-Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer
14天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
14天前
已完结
Systemic Treatment Strategies for Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A 20-y Retrospective Analysis With Clinical Insights
21天前
已完结
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study
1个月前
已完结
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
1个月前
已完结
Azacitidine for the treatment of relapsed and refractory AML in older patients
1个月前
已完结
Venetoclax in adult acute myeloid leukemia
1个月前
已完结
High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study
1个月前
已完结
DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIA
1个月前
已完结
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia
1个月前
已关闭
皖公网安备34019202002308
